Mitotane

Mitotane is used to treat cancer of the adrenal glands (adrenocortical carcinoma) that cannot be removed by surgery. This medicine acts on a part of the body called the adrenal cortex. Mitotane reduces the amount of steroids (cortisone-like hormones) that are produced by the adrenal cortex. It is grouped under the following drug class(es): Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lysodren, Chloditan, Chlodithane and Opeprim. Its PubChem CID is 4211.

CAS No 53-19-0
Molecular Formula C14H10Cl4
Molecular Weight 320.00 g/mol
Synonyms 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene

Frequently Asked Questions